NYSE · Analyst Forecast

Novo Nordisk A/S (NVO) Stock Forecast & Price Target

$40.56 NYSE: NVO Market Cap $178.78B

Price as of Nov 17, 2026 (intraday, delayed) · Analyst estimates retrieved Nov 11, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Novo Nordisk A/S (NVO), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Novo Nordisk A/S, analysts forecast revenue rising from DKK 307.98B in 2025 to DKK 376.12B in 2030; the average estimate for 2030 earnings per share is DKK 29.16; with published estimates ranging from DKK 27.16 to DKK 31.78; 16 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$40.56
Consensus targetThe average of the price targets analysts have published.$42.33
Median targetThe middle target, less affected by a single outlier.$40.00
Highest targetThe most optimistic published target.$47.00
Lowest targetThe most pessimistic published target.$40.00
Difference from priceHow far the consensus target sits from today’s price.+4.4%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (DKK)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025DKK 305.41BDKK 307.98BDKK 310.16B14
2026DKK 299.87BDKK 309.50BDKK 325.21B16
2027DKK 307.15BDKK 315.09BDKK 325.54B15
2028DKK 316.16BDKK 333.78BDKK 356.90B6
2029DKK 340.15BDKK 359.11BDKK 383.98B10
2030DKK 356.26BDKK 376.12BDKK 402.17B7

Earnings per share forecast (DKK)

YearLowAverageHighAnalysts
2025DKK 23.21DKK 23.54DKK 23.8014
2026DKK 21.85DKK 22.94DKK 24.6416
2027DKK 21.44DKK 22.62DKK 23.5415
2028DKK 22.78DKK 24.46DKK 26.666
2029DKK 24.93DKK 26.76DKK 29.1710
2030DKK 27.16DKK 29.16DKK 31.787

Novo Nordisk A/S (NVO) forecast — frequently asked questions

What is the analyst price target for Novo Nordisk A/S?

Analysts covering Novo Nordisk A/S (NVO) have a consensus price target of $42.33, 4.4% above the current price of $40.56. Published targets range from $40.00 to $47.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for Novo Nordisk A/S's earnings?

The average analyst estimate for Novo Nordisk A/S (NVO) earnings per share in 2030 is 29.16, with individual estimates between 27.16 and 31.78.

How much revenue is Novo Nordisk A/S expected to make?

Analysts forecast Novo Nordisk A/S (NVO) revenue of DKK 376.12B in 2030, based on 7 published estimates.

How many analysts cover NVO?

16 analysts contribute estimates for Novo Nordisk A/S (NVO). Thin coverage makes an average less reliable.

Analyst forecasts for other Drug Manufacturers - General stocks

LLY forecastJNJ forecastABBV forecastMRK forecastNVS forecastAZN forecastAMGN forecastGILD forecastPFE forecastBMY forecastAll Drug Manufacturers - General stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNYSE High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.